Braunschweig, Germany

Ahmed S Ahmed

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ahmed S Ahmed. Retrieved from https://idiyas.com/inventor/ahmed-s-ahmed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ahmed S Ahmed: Innovator in Pharmaceutical Research

Introduction

Ahmed S Ahmed is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target bacterial infections.

Latest Patents

Ahmed holds a patent for "PqsR inverse agonists." This invention relates to compounds that act as inverse agonists of PqsR, the only known receptor for the Quinolone Signal (PQS). The patent includes a pharmaceutical composition containing these compounds, as well as a combination preparation that includes at least one of the compounds and another active pharmaceutical ingredient. The uses of these compounds extend to their application as medicaments, particularly in the treatment or prophylaxis of bacterial infections.

Career Highlights

Ahmed is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he engages in groundbreaking research. His work focuses on innovative solutions to combat bacterial infections, contributing to advancements in medical science.

Collaborations

Some of his notable coworkers include Christian Schütz and Martin Empting, who collaborate with him on various research projects.

Conclusion

Ahmed S Ahmed's contributions to pharmaceutical research and his innovative patent for PqsR inverse agonists highlight his role as a key figure in the fight against bacterial infections. His work continues to pave the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…